| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,055 |
3,055 |
$410K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,169 |
3,071 |
$321K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,919 |
2,831 |
$216K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,711 |
1,683 |
$179K |
| 99233 |
Prolong inpt eval add15 m |
1,399 |
769 |
$139K |
| 99223 |
Prolong inpt eval add15 m |
757 |
743 |
$124K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
799 |
798 |
$123K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
236 |
236 |
$32K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
369 |
363 |
$25K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
488 |
299 |
$16K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
424 |
423 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
66 |
66 |
$6K |
| 99221 |
|
65 |
65 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
40 |
40 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
106 |
106 |
$884.88 |
| 81025 |
|
96 |
90 |
$727.70 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$584.88 |
| 82962 |
|
151 |
151 |
$426.79 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
13 |
$382.72 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
26 |
25 |
$370.27 |
| 99152 |
|
14 |
13 |
$149.78 |
| 90686 |
|
88 |
88 |
$20.15 |
| 90651 |
|
13 |
13 |
$0.00 |